Analyst Ratings for Rhythm Pharmaceuticals (RYTM) [Buys]

RYTM Rating Summary

RYTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RYTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $50.75 (+125.1%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/12/2019 Stifel
» Updated 5/4/2021
Derek C. Archilia Upgrade Buy
(Hold)
61.00
(60.00)
21.75
(22.55)
3.68% Details
7/8/2019 Canaccord Genuity
» Updated 5/5/2020
N/A New Coverage Buy
(N/A)
31.00
(35.00)
21.26
(22.55)
6.07% Details
Like RYTM Ratings? Also take a look at GMDA, PEG

RYTM Ratings News